AMCR
Amcor plc
AMCR has the edge over RIVN overall, supported by stronger fundamentals and lower modeled downside.
RIVN
Rivian Automotive, Inc.
RIVN offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
AMCR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
AMCR's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AMCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $38.71 | -12% |
| Current | 19x | $43.80 | — |
| Fair | 21x | $49.43 | +13% |
| Expensive | 28x | $64.25 | +47% |
Historical ranges are pointers, not guarantees.
AMCR's PE is in its cheap range at 19x.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
AMCR Forward outlook
There aren't enough analyst estimates for AMCR to show an outlook.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AMCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.33 | +36% |
| Q2 2026 | $2.38 | +31% |
| Q1 2026 | $1.45 | -48% |
| Q4 2025 | $1.53 | -45% |
| Q3 2025 | $1.71 | -36% |
| Q2 2025 | $1.81 | -28% |
| Q1 2025 | $2.80 | +24% |
| Q4 2024 | $2.76 | +25% |
AMCR has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
AMCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.1B | +6.7% |
| Q2 2026 | $6.4B | +26% |
| Q1 2026 | $5.9B | +77% |
| Q4 2025 | $5.4B | +68% |
| Q3 2025 | $5.7B | +71% |
| Q2 2025 | $5.1B | +44% |
| Q1 2025 | $3.3B | -2.3% |
| Q4 2024 | $3.2B | -0.3% |
AMCR's revenue has grown year over year for six quarters in a row: $6.1B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.6 points |
| Q2 2026 | 10% | +8.4 points |
| Q1 2026 | 7.8% | -1.6 points |
| Q4 2025 | 6.1% | -3.1 points |
| Q3 2025 | 8% | -1.3 points |
| Q2 2025 | 1.7% | -9.5 points |
| Q1 2025 | 9.4% | +0.4 points |
| Q4 2024 | 9.2% | +1.7 points |
AMCR has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
AMCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$828M | -$457M |
| Q2 2026 | $1.4B | +52% |
| Q1 2026 | -$42M | -$42M |
| Q4 2025 | $282M | -15% |
| Q3 2025 | -$371M | +$43M |
| Q2 2025 | $894M | +11% |
| Q1 2025 | $0 | -100% |
| Q4 2024 | $330M | +36% |
AMCR has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
AMCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 5.2x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 6.7x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.5x | Elevated |
AMCR's net debt is about 4.2 years of its operating earnings (EBITDA), down from 6.7 years a year ago.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 53.5 | Neutral |
AMCR's weekly RSI is 50 (neutral) and its Stochastic is 54 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
AMCR PE vs Consumer Cyclical Sector
| Metric | AMCR | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 4.1% above |
| PE % | 27 | 47 | 20 pts below |
AMCR is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
AMCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.0 | 0.5% below |
| 20 week MA | $44.6 | 1.8% below |
| 50 week MA | $42.9 | 2% above |
| 100 week MA | $44.3 | 1.2% below |
| 200 week MA | $47.4 | 7.5% below |
AMCR has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
AMCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.8 | $58.2 | +6.3% |
| 2021 | $58.2 | $58.3 | +0.2% |
| 2022 | $58.3 | $60.3 | +3.4% |
| 2023 | $60.3 | $48.2 | -20% |
| 2024 | $48.2 | $47.2 | -2.1% |
| 2025 | $47.2 | $41.6 | -12% |
| 2026 YTD | $41.6 | $43.8 | +5.3% |
AMCR has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.